In the TCGA and CGGA databases (mRNA-array_301, mRNAseq_325 and mRNAseq_693), the GSEA results showed that high HYAL2 expression resulted in significant enrichment of the cell cycle and apoptosis pathways in glioma (Fig. 6A, D). This evidence concerns the gene HYAL2 and central nervous system cancer.